Porvair plc (LON:PRV – Get Free Report) insider James Mills purchased 3,897 shares of the firm’s stock in a transaction that occurred on Thursday, October 15th. The stock was bought at an average cost of GBX 890 per share, for a total transaction of £34,683.30.
Porvair Stock Performance
Shares of LON:PRV opened at GBX 872 on Wednesday. The business’s fifty day moving average price is GBX 870.83 and its two-hundred day moving average price is GBX 821.80. Porvair plc has a fifty-two week low of GBX 678.82 and a fifty-two week high of GBX 938. The stock has a market capitalization of £402.91 million, a price-to-earnings ratio of 21.58 and a beta of 0.52. The company has a debt-to-equity ratio of 14.49, a current ratio of 1.94 and a quick ratio of 1.22.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on PRV shares. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 1,050 target price on shares of Porvair in a research note on Thursday, October 15th. Berenberg Bank lowered their target price on shares of Porvair from GBX 1,050 to GBX 1,000 and set a “buy” rating on the stock in a report on Thursday, October 15th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of GBX 1,025.
Read Our Latest Stock Analysis on PRV
About Porvair
Porvair plc engages in the filtration, laboratory, and environmental technology business. It operates through three segments: Aerospace & Industrial, Laboratory, and Metal Melt Quality. The Aerospace & Industrial segment designs and manufactures a range of specialist filtration equipment for aerospace, energy, and industrial applications. The Laboratory segment is involved in the design and manufacture of instruments and consumables for use in environmental and bioscience laboratories with a focus on water analysis instruments, diagnostics, and sample preparation equipment.
See Also
- Five stocks we like better than Porvair
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Receive News & Ratings for Porvair Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Porvair and related companies with MarketBeat.com's FREE daily email newsletter.
